STEM Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.

Press releases published on October 28, 2026

16 hours ago

Synology and Carahsoft Partner to Bring Enterprise-Grade Data Protection to the Public Sector

Indeterminate GlobeNewswire

16 hours ago

Kobalt Labs Named to the 2026 CB Insights’ 100 Most Promising Fintech Startups

Indeterminate GlobeNewswire

16 hours ago

3 E Network Technology Group Limited Announces Further Share Consolidation Resulting in a Cumulative 4 for 1 Ratio

Indeterminate GlobeNewswire

16 hours ago

InboxAlly, a Leading Email Deliverability Platform, Highlights Email Blacklist Risks and Steps to Protect Deliverability

Indeterminate GlobeNewswire

16 hours ago

0G and xBuilders Issue Final Call for $20M Apollo AI Accelerator Cohort 2

Indeterminate GlobeNewswire

17 hours ago

EasyVend Announces Unified B2B Order Management Platform for Australian Food and Beverage Distributors

Indeterminate GlobeNewswire

17 hours ago

SHI Named a Leader in the 2026 Gartner® Magic Quadrant™ for SAM Managed Services

Indeterminate GlobeNewswire

17 hours ago

Summit Expands Ashburn Data Center Capacity by 60% as Hyperscale Demand Squeezes Enterprise Colocation Market

Indeterminate GlobeNewswire

17 hours ago

Lakeside Software Cited as a Leader in Digital Employee Experience Management by Independent Research Firm

Indeterminate GlobeNewswire

17 hours ago

Worth Named to the 2026 CB Insights’ 100 Most Promising Fintech Startups

Indeterminate GlobeNewswire

17 hours ago

Esker Appoints Matthias Goehler as Chief Product Officer

Indeterminate GlobeNewswire

18 hours ago

شركة AdipoPharma تُحرز تقدمًا في تطوير دواء PATAS من خلال الانتقال إلى المرحلة 1b من التجارب السريرية على مرضى السكري من النوع الثاني.

Indeterminate GlobeNewswire

18 hours ago

AdipoPharma startet klinische Phase-1b-Studie mit PATAS bei Patienten mit Typ-2-Diabetes

Indeterminate GlobeNewswire

18 hours ago

AdipoPharma lance la phase 1b des essais cliniques du peptide PATAS chez des patients atteints de diabète de type 2

Indeterminate GlobeNewswire

18 hours ago

ESET Research APT Report: Iran-aligned groups targeting expands; Belarus-aligned APT activity converges with Russia’s war priorities

Indeterminate GlobeNewswire

18 hours ago

EmpowerFresh and Loyalty Lane Announce Partnership to Bring AI-Driven Ordering and Inventory Management to Independent Grocers

Indeterminate GlobeNewswire

18 hours ago

Monte Carlo Launches Bayes, an AI Teammate That Fixes Production AI Agents and Their Data

Indeterminate GlobeNewswire

18 hours ago

Advantage Solutions Releases Two Proprietary Studies Revealing What Will Shape Retail in 2027

Indeterminate GlobeNewswire

18 hours ago

Interact joins Anthropic’s Cyber Verification Program to strengthen enterprise intranet security with Claude Mythos 5.1

Indeterminate GlobeNewswire

18 hours ago

Genmab Announces Statistically Significant, Clinically Meaningful Improvement in Overall Survival and Objective Response with Petosemtamab Combination at First Interim Analysis in First-Line R/M Patients with PD-L1+ Head and Neck Cancer

Indeterminate GlobeNewswire